Richard M. Stone, MD, talks about Incorporating Midostaurin for FLT3 Positive Patients Use Gemtuzumab Ozogamicin for CD33 Expression at Imedex Great Debates 2018.
Incorporate Midostaurin for FLT3 Positive Patients Use Gemtuzumab Ozogamicin for CD33 Expression
By Editor